Literature DB >> 8877066

Epidemiological studies on brassica vegetables and cancer risk.

D T Verhoeven1, R A Goldbohm, G van Poppel, H Verhagen, P A van den Brandt.   

Abstract

This paper gives an overview of the epidemiological data concerning the cancer-preventive effect of brassica vegetables, including cabbage, kale, broccoli, Brussels sprouts, and cauliflower. The protective effect of brassicas against cancer may be due to their relatively high content of glucosinolates. Certain hydrolysis products of glucosinolates have shown anticarcinogenic properties. The results of 7 cohort studies and 87 case-control studies on the association between brassica consumption and cancer risk are summarized. The cohort studies showed inverse associations between the consumption of cabbage, cauliflower, and broccoli and risk of lung cancer; between the consumption of brassicas and risk of stomach cancer; between broccoli consumption and risk of all cancers taken together; and between brassica consumption and the occurrence of second primary cancers. Of the case-control studies, 67% showed an inverse association between consumption of total brassica vegetables and risk of cancer at various sites. For cabbage, broccoli, cauliflower, and Brussels sprouts, these percentages were 70, 56, 67, and 29%, respectively. Although the measured effects might have been distorted by various types of bias, it is concluded that a high consumption of brassica vegetables is associated with a decreased risk of cancer. This association appears to be most consistent for lung, stomach, colon, and rectal cancer and least consistent for prostatic, endometrial, and ovarian cancer. It is not yet possible to resolve whether associations are to be attributed to brassica vegetables per se or to vegetables in general. Further epidemiological research should separate the anticarcinogenic effect of brassica vegetables from the effect of vegetables in general.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8877066

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  121 in total

Review 1.  Dietary Sulforaphane in Cancer Chemoprevention: The Role of Epigenetic Regulation and HDAC Inhibition.

Authors:  Stephanie M Tortorella; Simon G Royce; Paul V Licciardi; Tom C Karagiannis
Journal:  Antioxid Redox Signal       Date:  2014-12-19       Impact factor: 8.401

2.  A phase I dose-escalation study of oral BR-DIM (BioResponse 3,3'- Diindolylmethane) in castrate-resistant, non-metastatic prostate cancer.

Authors:  Elisabeth I Heath; Lance K Heilbrun; Jing Li; Ulka Vaishampayan; Felicity Harper; Pam Pemberton; Fazlul H Sarkar
Journal:  Am J Transl Res       Date:  2010-07-23       Impact factor: 4.060

Review 3.  Cancer stem cells: a novel paradigm for cancer prevention and treatment.

Authors:  Dharmalingam Subramaniam; Satish Ramalingam; Courtney W Houchen; Shrikant Anant
Journal:  Mini Rev Med Chem       Date:  2010-05       Impact factor: 3.862

Review 4.  Phenethyl isothiocyanate: a comprehensive review of anti-cancer mechanisms.

Authors:  Parul Gupta; Stephen E Wright; Sung-Hoon Kim; Sanjay K Srivastava
Journal:  Biochim Biophys Acta       Date:  2014-08-23

5.  Food as a source for quorum sensing inhibitors: iberin from horseradish revealed as a quorum sensing inhibitor of Pseudomonas aeruginosa.

Authors:  Tim Holm Jakobsen; Steinn Kristinn Bragason; Richard Kerry Phipps; Louise Dahl Christensen; Maria van Gennip; Morten Alhede; Mette Skindersoe; Thomas Ostenfeld Larsen; Niels Høiby; Thomas Bjarnsholt; Michael Givskov
Journal:  Appl Environ Microbiol       Date:  2012-01-27       Impact factor: 4.792

6.  Differential response of normal (PrEC) and cancerous human prostate cells (PC-3) to phenethyl isothiocyanate-mediated changes in expression of antioxidant defense genes.

Authors:  Anna A Powolny; Shivendra V Singh
Journal:  Pharm Res       Date:  2010-09-25       Impact factor: 4.200

7.  Phenethyl isothiocyanate hampers growth and progression of HER2-positive breast and ovarian carcinoma by targeting their stem cell compartment.

Authors:  Ada Koschorke; Simona Faraci; Debora Giani; Claudia Chiodoni; Egidio Iorio; Rossella Canese; Mario P Colombo; Alessia Lamolinara; Manuela Iezzi; Michael Ladomery; Claudio Vernieri; Filippo de Braud; Massimo Di Nicola; Elda Tagliabue; Lorenzo Castagnoli; Serenella M Pupa
Journal:  Cell Oncol (Dordr)       Date:  2019-08-02       Impact factor: 6.730

8.  Suppression of microtubule dynamic instability and turnover in MCF7 breast cancer cells by sulforaphane.

Authors:  Olga Azarenko; Tatiana Okouneva; Keith W Singletary; Mary Ann Jordan; Leslie Wilson
Journal:  Carcinogenesis       Date:  2008-10-23       Impact factor: 4.944

9.  Sulforaphane and related mustard oils in focus of cancer prevention and therapy.

Authors:  Ingrid Herr; Vladimir Lozanovski; Philipp Houben; Peter Schemmer; Markus W Büchler
Journal:  Wien Med Wochenschr       Date:  2012-12-07

10.  Indoles mitigate the development of experimental autoimmune encephalomyelitis by induction of reciprocal differentiation of regulatory T cells and Th17 cells.

Authors:  Michael Rouse; Narendra P Singh; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  Br J Pharmacol       Date:  2013-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.